FRA
MRNA icon

Frank Rimerman Advisors’s Moderna MRNA Stock Holding History

Frank Rimerman Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,152
Closed -$374K – 555
2024
Q2 		$374K Buy
3,152
+2,451
+350% +$310K 0.03% 405
2024
Q1 		$74.7K Buy
+701
New +$70.7K 0.01% 115
2021
Q4 		– Sell
-556
Closed -$214K – 120
2021
Q3 		$214K Buy
+556
New +$205K 0.08% 103

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Frank Rimerman Advisors's MRNA Position: Q3 2024 in Review

Frank Rimerman Advisors sold out of Moderna (MRNA) in Q3 2024, closing a stake of 3,152 shares — an estimated $374K sold.

Frank Rimerman Advisors first reported a position in MRNA in Q3 2021 and held it in 3 quarters. The position peaked at $374K in Q2 2024. 788 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • Frank Rimerman Advisors reported no remaining Moderna position as of Q3 2024 after selling out during the quarter.
  • Frank Rimerman Advisors sold 3,152 Moderna shares in Q3 2024, an estimated $374K.
  • Frank Rimerman Advisors first reported a position in Moderna in Q3 2021 and held it in 3 quarters.
  • Frank Rimerman Advisors's Moderna position peaked at $374K in Q2 2024.
  • 788 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on Frank Rimerman Advisors's 13F filing for Q3 2024, filed 24 Oct 2024.